FindTrial
Sign In

Artificial Pancreas

DEVICE11 trials

Sponsors

Kochi University, University of Padova, University of Virginia, McGill University, Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Conditions

Cardiovascular DiseasesDiabetesDiabetes Mellitus, Type 1End Stage Renal Disease (ESRD)Hyperglycemia, PostprandialInsulin-requiring Type 2 Diabetes MellitusPancreatic DiseasePostprandial Hyperglycemia

Phase 3

Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting
CompletedNCT03979352
Samuel Lunenfeld Research Institute, Mount Sinai HospitalType1 Diabetes Mellitus
Start: 2019-08-01End: 2021-08-31Updated: 2022-06-07

Unknown Phase

Tight Glycemic Control by Artificial Pancreas
NCT00735228
Kochi UniversityCardiovascular Diseases, Pancreatic Disease
Start: 2008-08-31End: 2012-08-31Target: 400Updated: 2008-08-18
Artificial Pancreas in Pediatric Patients (PEDarPAN)
CompletedNCT02620878
University of PadovaType 1 Diabetes
Start: 2015-07-31End: 2015-09-30Updated: 2019-07-12
International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol
CompletedNCT02844517
University of VirginiaDiabetes Mellitus, Type 1
Start: 2016-11-30End: 2017-10-31Updated: 2018-05-07
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
CompletedNCT02985866
University of VirginiaType1 Diabetes Mellitus
Start: 2017-10-27End: 2018-09-04Updated: 2022-12-05
Efficacy of Closed-Loop Strategy With and Without a Learning Component in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp
CompletedNCT03581968
McGill UniversityDiabetes, Type 1 Diabetes Mellitus
Start: 2018-07-02End: 2018-08-10Updated: 2018-11-29
Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas
CompletedNCT04163874
McGill UniversityHyperglycemia, Postprandial, Type 1 Diabetes, Type 1 Diabetes Mellitus
Start: 2020-02-14End: 2022-01-30Updated: 2022-10-10
Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney Transplantation
WithdrawnNCT04189510
University of VirginiaEnd Stage Renal Disease (ESRD), Insulin-requiring Type 2 Diabetes Mellitus, Type 1 Diabetes
Start: 2021-04-01End: 2021-12-31Updated: 2021-11-10
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
NCT04243629
McGill UniversityDiabetes Mellitus, Type 1, Postprandial Hyperglycemia, Type 1 Diabetes
Start: 2021-11-12End: 2024-04-30Target: 26Updated: 2023-03-15
Algorithm to control Postprandial, Post exercise and night glucose Excursions in a portable Closed Loop format in patients after Total Pancreatectomy
RecruitingNL-OMON20928
Amsterdam UMC (Academic Medical Center)Total pancreatectomy after any indication
Start: 2020-09-06Target: 12Updated: 2024-02-28
A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
CompletedNCT05199714
McGill University Health Centre/Research Institute of the McGill University Health CentreType 1 Diabetes
Start: 2022-02-21End: 2023-03-25Updated: 2023-10-25

Related Papers

Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.
2024-07-018 citations
Randomized Controlled Trial of Mobile Closed-Loop Control
Diabetes Care2020-01-1460 citations